GLOW is a compounded peptide blend formulated for skin rejuvenation and collagen synthesis, typically combining GHK-Cu, BPC-157, and other dermatologic peptides in a single vial for aesthetic anti-aging applications.
Peptide Blend
GLOW is a compounded peptide blend formulated for skin rejuvenation and collagen synthesis, typically combining GHK-Cu, BPC-157, and other dermatologic peptides in a single vial for aesthetic anti-aging applications.
Research Use Only — not intended for human consumption
Research peptides are sold for laboratory use only and are not intended for human consumption.
1 clinic in our directory offer GLOW. Use the button below to find one near you.
Find a Peptide Clinic Near YouPeptide Blend
Adamax is a branded compounded peptide blend typically combining CJC-1295 DAC, Ipamorelin, and BPC-157, formulated to simultaneously stimulate growth hormone secretion, promote tissue repair, and support recovery — often available as a single reconstitution vial.
Peptide Blend
CagriSema, a compounded combination of the amylin analogue cagrilintide and the GLP-1 agonist semaglutide, studied in Phase 3 REDEFINE trials with approximately 22.7% body weight reduction at 68 weeks.
Peptide Blend
A triple-peptide compounded blend combining AOD-9604 (fat-mobilizing GH fragment) with CJC-1295 and ipamorelin for comprehensive GH-axis optimization with targeted lipolysis.
Peptide Blend
A compounded blend combining ipamorelin (ghrelin receptor agonist) with tesamorelin (GHRH analogue) for synergistic GH secretion with tesamorelin's additional visceral fat-reducing properties.
Articles about GLOW and related topics
GuidesDiscover what to realistically expect from BPC-157, TB-500, and GHK-Cu (Glow Blend) therapy in terms of timelines, outcomes, and influencing factors.
Dosage GuidesDiscover the definitive dosage guide for BPC-157, TB-500, and GHK-Cu (Glow Blend). Learn about standard dosing ranges, administration methods, and how to optimize your peptide therapy.
Peptide Sciences, the largest grey-market research peptide vendor in the US, voluntarily shut down on March 6, 2026. Here is what happened, why it closed, and what the closure means for researchers and the broader peptide industry.
MyPeptideMatch.com does not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy. Regulatory status may change.